| Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 32.35 mm | 32.35 mm | 32.35 mm | 32.35 mm | 32.35 mm | 32.35 mm |
| Cash burn (monthly) | 5.53 mm | (no burn) | 2.08 mm | 2.31 mm | 584.67 k | 1.42 mm |
| Cash used (since last report) | 15.58 mm | n/a | 5.87 mm | 6.51 mm | 1.65 mm | 4.01 mm |
| Cash remaining | 16.77 mm | n/a | 26.48 mm | 25.84 mm | 30.70 mm | 28.34 mm |
| Runway (months of cash) | 3.0 | n/a | 12.7 | 11.2 | 52.5 | 19.9 |
| 13F holders | Current |
|---|---|
| Total holders | 12 |
| Opened positions | 5 |
| Closed positions | 12 |
| Increased positions | 1 |
| Reduced positions | 3 |
| 13F shares | Current |
|---|---|
| Total value | 6.48 bn |
| Total shares | 76.22 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Vivo Opportunity Fund | 59.96 mm | $73.15 mm |
| Biotechnology Value Fund L P | 3.47 mm | $5.87 mm |
| Logos Global Management | 3.47 mm | $1.74 bn |
| Nantahala Capital Management | 2.82 mm | $1.41 bn |
| Ra Capital Management | 2.63 mm | $1.32 bn |
| BVF | 2.20 mm | $1.10 bn |
| Rosalind Advisors | 1.57 mm | $787.33 mm |
| STT State Street | 43.94 k | $22.02 mm |
| Captrust Financial Advisors | 18.80 k | $9.42 mm |
| Tandem Capital Management | 15.50 k | $7.08 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 9 Oct 24 | Aggarwal Gaurav | Common Stock | Conversion | Acquire C | Yes | No | 0 | 5,500,000 | 0.00 | 9,970,152 |
| 9 Oct 24 | Aggarwal Gaurav | Series A-2 Prime Preferred Stock Common Stock | Sale back to company | Dispose D | Yes | No | 1000 | 2,695 | 2.70 mm | 3,885.21 |
| 12 Aug 24 | Douglas Jermasek | Stock Options Common Stock | Grant | Acquire A | No | No | 0.34 | 81,750 | 27.80 k | 2,055,000 |
| 12 Aug 24 | Shalabh K. Gupta | Stock Options Common Stock | Grant | Acquire A | No | No | 0.34 | 232,868 | 79.18 k | 6,439,505 |
| 12 Aug 24 | John Townsend | Stock Options Common Stock | Grant | Acquire A | No | No | 0.34 | 40,256 | 13.69 k | 915,565 |
| 12 Aug 24 | Pramod Gupta | Stock Options Common Stock | Grant | Acquire A | No | No | 0.34 | 81,750 | 27.80 k | 2,119,862 |
